Monomethyl triazeno imidazole carboxamide
CAS: 3413-72-7
Ref. 3D-FM26098
1mg | 156,00 € | ||
2mg | 217,00 € | ||
5mg | 325,00 € | ||
10mg | 406,00 € | ||
25mg | 633,00 € |
Informação sobre produto
- MTIC3-methyl(triazenyl)imidazole-4-carboxamide5-(3-methyltriazen-1-yl)imidazole-4-carboxamide
- NSC 407347
Monomethyl triazeno imidazole carboxamide (MTIC) is a drug that is used to treat cancer. It has been shown to inhibit the proliferation of tumor cells and induce apoptosis by inhibiting the expression of proteins, such as Bcl-2, which are involved in regulating mitochondrial membrane potential. MTIC has also been shown to inhibit protein synthesis and cell signaling pathways, such as the PI3K/Akt pathway. The use of MTIC for diagnosis purposes can be achieved using electrochemical impedance spectroscopy. A concentration-time curve can be obtained by incubating a biological sample with MTIC and measuring cell response using an impedance spectrophotometer. The clinical properties of MTIC include its ability to be administered orally or intravenously, have low toxicity, and inhibit the growth of tumor cells in vivo and in vitro.
Propriedades químicas
Consulta técnica sobre: 3D-FM26098 Monomethyl triazeno imidazole carboxamide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.